Skip to main content
OpenTrials

Clinical trial condition

Recurrent Extrahepatic Bile Duct Carcinoma

Explore clinical trials studying Recurrent Extrahepatic Bile Duct Carcinoma. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Extrahepatic Bile Duct Carcinoma trial results

Completed

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

NCT02042443

Conditions
Adenocarcinoma, Adult Cholangiocarcinoma, Advanced Adult Hepatocellular Carcinoma, +35 more
Locations
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Anchorage Oncology Centre Anchorage, Alaska, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
View all 295 locations
View Trial Details
Completed

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma

NCT01093222

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +22 more
Locations
  • The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Fremont - Rideout Cancer Center Marysville, California, United States
View all 141 locations
View Trial Details

Related conditions